Formulation Considerations for the Management of Dry Eye Disease
Dry eye disease (DED) is one of the most common ocular surface disorders characterised by a deficiency in quality and/or quantity of the tear fluid. Due to its multifactorial nature involving several inter-related underlying pathologies, it can rapidly accelerate to become a chronic refractory condi...
Saved in:
Main Authors: | Priyanka Agarwal (Author), Jennifer P. Craig (Author), Ilva D. Rupenthal (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preparation and Characterisation of a Cyclodextrin-Complexed Mānuka Honey Microemulsion for Eyelid Application
by: Ilva D. Rupenthal, et al.
Published: (2022) -
Utilizing an Ex Vivo Skin Penetration Analysis Model for Predicting Ocular Drug Penetration: A Feasibility Study with Curcumin Formulations
by: Christian Raab, et al.
Published: (2024) -
Development and content validity assessment of the Dry Eye Disease Questionnaire in patients with dry eye disease, meibomian gland dysfunction, and Sjögren's syndrome dry eye disease
by: Brigitte Sloesen, et al.
Published: (2023) -
In Vitro Inhibition of Evaporation with Perfluorohexyloctane, an Eye Drop for Dry Eye Disease
by: Jason Vittitow, Ph.D, et al.
Published: (2023) -
Extended release promethazine HCl using acrylic polymers by freeze-drying and spray-drying techniques: formulation considerations
by: Ruchi Tiwari, et al.
Published: (2009)